| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/10/2007 | US7202073 Human analogs of murine deubiquitinating proteases |
| 04/10/2007 | US7202071 Peptidyl t-RNA hydrolase (PTH) |
| 04/10/2007 | US7202067 Carotene synthase gene and uses therefor |
| 04/10/2007 | US7202066 Synergistic healing the wounds |
| 04/10/2007 | US7202065 Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme |
| 04/10/2007 | US7202056 Polynucleotides encoding a human cell surface protein with immunoglobulin folds, BGS-19 |
| 04/10/2007 | US7202053 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein |
| 04/10/2007 | US7202052 Regulatory protein for use in induction of nicotinamide adenine dinucleotide oxidase (NOX) for use as free radical quencher in prevention and treatment of cardiovascular and cell proliferative disorders |
| 04/10/2007 | US7202049 Mitogen-activated protein kinase p38-2 and methods of use therefor |
| 04/10/2007 | US7202048 Identifying a thrombin generation time for a blood sample to assess risk of bleeding, to diagnose various disorders, and to monitor the effects of pharmaceutical and other treatments. |
| 04/10/2007 | US7202044 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents |
| 04/10/2007 | US7202040 Method for screening compounds which change the binding properties of a protein with a ligand |
| 04/10/2007 | US7202034 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
| 04/10/2007 | US7202025 Control of gene expression |
| 04/10/2007 | US7201919 Mixture for transdermal delivery of low and high molecular weight compounds |
| 04/10/2007 | US7201905 Fusion protein, comprising a receptor-antagonizing domain (such as prolactin receptor antagonist) and a positive immunomodulator domain (such as an interleukin); combines apoptosis induction and immunotherapy |
| 04/10/2007 | US7201903 Method and device for detecting feline immunodeficiency virus |
| 04/10/2007 | US7201900 Comprises immunoglobulin for diagnosis, prognosis, detection and treatment of cancer; immunoassay; antitumor agents |
| 04/10/2007 | US7201899 Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 04/10/2007 | US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/10/2007 | US7201897 Interferon conjugates |
| 04/10/2007 | US7201896 IL6RIL6 chimera for the treatment of neurodegenerative diseases |
| 04/10/2007 | US7201895 High-affinity antagonists of ELR-CXC chemokines |
| 04/10/2007 | US7201892 using carbocyanine dyes; photodynamic therapy; supplying to tumors |
| 04/10/2007 | CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2364199C Novel bicyclic derivatives of aminopyrazinone, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2323151C Biodegradable polymer/protein based coils for intralumenal implants |
| 04/10/2007 | CA2319668C Human tsc403 gene and human ing1l gene |
| 04/10/2007 | CA2297924C Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein |
| 04/10/2007 | CA2258601C Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier |
| 04/10/2007 | CA2254931C Human monoclonal antibodies to the hepatitis b surface antigen |
| 04/10/2007 | CA2236001C Biologically active eph family ligands |
| 04/10/2007 | CA2226880C Cyclosporin derivatives with anti-hiv effect |
| 04/10/2007 | CA2222068C Chimeric fatty body-pro-grf analogs with increased biological potency |
| 04/10/2007 | CA2209172C Murine monoclonal anti-idiotype antibody 3h1 |
| 04/10/2007 | CA2197209C Aza cyclohexapeptide compounds |
| 04/10/2007 | CA2190108C Somatostatin binding peptide-metal chelate conjugates |
| 04/10/2007 | CA2179041C Biphasic capsule formulation |
| 04/10/2007 | CA2171289C Il8 inhibitors |
| 04/10/2007 | CA2170739C Method to reduce myocardial injury during acute myocardial infarction |
| 04/10/2007 | CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation |
| 04/10/2007 | CA2148194C Cyclopeptides of the formula i |
| 04/10/2007 | CA2125174C Novel polypeptides for promoting cell attachment |
| 04/10/2007 | CA2102447C Cyclopeptides |
| 04/07/2007 | CA2562767A1 Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| 04/06/2007 | CA2561768A1 Intraluminal device and therapeutic agent combination for treating aneurysmal disease |
| 04/05/2007 | WO2007038772A1 Novel drugs for dementia |
| 04/05/2007 | WO2007038749A2 Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation |
| 04/05/2007 | WO2007038733A1 Method for enhancing effects of colorants and conditioners |
| 04/05/2007 | WO2007038687A2 Ocular administration of immunosuppressive agents |
| 04/05/2007 | WO2007038686A2 Amniotic membrane preparations and purified compositions and methods of use |
| 04/05/2007 | WO2007038683A2 Calcium binding peptides |
| 04/05/2007 | WO2007038678A2 Analogs of ghrelin |
| 04/05/2007 | WO2007038623A2 Oral formulation for enteric disorders and/or rehydration |
| 04/05/2007 | WO2007038548A2 Compositions and methods of using chondroitinase abci mutants |
| 04/05/2007 | WO2007038407A2 Compositions and methods for treating nervous system disorders |
| 04/05/2007 | WO2007038386A2 Method for enhancing immune responses in mammals |
| 04/05/2007 | WO2007038291A1 Black tea polyphenols and uses thereof |
| 04/05/2007 | WO2007037514A1 Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposes |
| 04/05/2007 | WO2007037413A1 Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink for inhibiting postprandial increase in blood sugar level |
| 04/05/2007 | WO2007037297A1 Composition effective for prevention and treatment of adult disease |
| 04/05/2007 | WO2007037273A1 Introduction of substance into cell by using nanoparticle having cell membrane-permeable peptide displayed thereon |
| 04/05/2007 | WO2007037265A1 Dna vaccine composition |
| 04/05/2007 | WO2007037245A1 Polypeptide having anti-angiogenic activity |
| 04/05/2007 | WO2007037099A1 Remedy for mastitis |
| 04/05/2007 | WO2007037098A1 Reproductive disorder remedy |
| 04/05/2007 | WO2007037060A1 Composition for acceleration of type i collagen production |
| 04/05/2007 | WO2007036945A2 Hepatocyte growth factor receptor splice variants and methods of using same |
| 04/05/2007 | WO2007036706A1 Variants of the lantibiotic mersacidin and their use |
| 04/05/2007 | WO2007036638A1 Cd4+ t survivin epitopes and uses thereof |
| 04/05/2007 | WO2007036107A1 An exterior-applied formulation and its preparation methods and uses |
| 04/05/2007 | WO2007036053A1 Inhibitors of ste20-like kinase (slk) and methods of modulating cell cycle progression and cell motility |
| 04/05/2007 | WO2007036041A1 Sialidase inhibitors for the treatment of cardiovascular disease |
| 04/05/2007 | WO2007036036A1 Method and composition for increasing the engraftment efficiency of stem cells |
| 04/05/2007 | WO2007036033A1 Oligodendrocyte precursor cell proliferation regulated by prolactin |
| 04/05/2007 | WO2007036028A1 Compositions for and methods of granzyme b inhibition |
| 04/05/2007 | WO2007020386A3 Apoe mimetic agents |
| 04/05/2007 | WO2007015638A3 Methods and means for controlling the endocytosis and subsequent degradation of a cell surface protein |
| 04/05/2007 | WO2007012033A9 Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| 04/05/2007 | WO2007011670A3 Heterodimeric four helix bundle cytokines |
| 04/05/2007 | WO2007007985A3 Ligand of regulating immune response, and use thereof in treating an immune response-related disease |
| 04/05/2007 | WO2007007982A3 Glucose uptake modulator and method for treating diabetes or diabetic complications |
| 04/05/2007 | WO2007007060A3 N- or c- terminally modified small peptides |
| 04/05/2007 | WO2007005995A9 Compositions for buccal delivery of human growth hormone |
| 04/05/2007 | WO2007003958A3 Methods for tissue engineering |
| 04/05/2007 | WO2007002145A3 Lysozyme-based food stuff |
| 04/05/2007 | WO2006138708B1 Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 04/05/2007 | WO2006128190B1 Compositions and methods for treatment of neural disorders using transforming growth factor-beta superfamily proteins and their antagonists |
| 04/05/2007 | WO2006125645A3 Inhibitors of mmp-15 in cancer treatment |
| 04/05/2007 | WO2006122652A3 Thiosuccinic acid derivatives and the use thereof |
| 04/05/2007 | WO2006119527A3 Melanoma-associated endogenous retrovirus (merv) derived peptide sequences and their therapeutic/ diagnostic use |
| 04/05/2007 | WO2006112930A3 Q3 sparc deletion mutant and uses thereof |
| 04/05/2007 | WO2006097535A3 Peptide agonists of the glucagon family with secretin like activity |
| 04/05/2007 | WO2006094384B1 Use of interleukin 17e for the treatment of cancer |
| 04/05/2007 | WO2006091728A3 Microtubule stabilizing compounds and methods of their use |
| 04/05/2007 | WO2006089043A3 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis |
| 04/05/2007 | WO2006074787A3 Polypeptide species useful for the treatment of neurological disorders |
| 04/05/2007 | WO2006073601A3 Methods and compositions for rna interference |
| 04/05/2007 | WO2006067633A3 Conjugation product |
| 04/05/2007 | WO2006028429A3 Peptides for targeting the prostate specific membrane antigen |